Search
for
Sort by
Research 31–60 of 1000+
- Polycystic Ovarian Syndrome
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Health and fertility in World Health Organization group 2 anovulatory women
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Role of OCT4 in the Regulation of FSH-Induced Granulosa Cells Growth in Female Mice
- New hyaluronan-based biomatrix for 3-D follicle culture yields functionally competent oocytes
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- Nutritional Management of Menopausal Women
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Polycystic Ovary Syndrome
- Exploring the therapeutic potential of metformin in polycystic ovary syndrome: focusing on hyperandrogenism in a sample of Iraqi women
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Polycystic Ovary Syndrome
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Compliance With Contraceptives and Other Treatments
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Polycystic Ovary Syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model